Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,166.8
-16.2 (-0.51%)

 

  • STI Straits Times Index
    3,166.8
    -16.2 (-0.51%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,599.5
    -4.8 (-0.30%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,754.1
    -36.1 (-0.13%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,985.7
    7.5 (0.25%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,960.7
    -40.6 (-0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,276.6
    39.9 (0.64%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,070.7
    8.4 (0.41%)
    Index delayed 20 minutes
  • XAO XAO
    6,791.2
    -10.5 (-0.15%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 726.6M
  • Value: 896.1M
  • Rise: 134
  • Fall: 155
  • Unch: 544

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.088-0.005
TEE Intl0.046+0.004
YZJ Shipbldg SGD1.050-0.030
Spackman0.013+0.001
Mapletree Ind Tr2.400+0.070
Keppel DC Reit1.970+0.040
Kep Infra Tr0.525+0.005
LionGold0.001-
Medtecs Intl0.039+0.007
Mapletree Com Tr2.220+0.060

World Indices

World Indices
Name Last Change
Nasdaq 8,186.0 +32.5
HSI 26,754.1 -36.1
HSCEI 10,478.5 -23.9
Jakarta 6,276.6 +39.9
Nikkei 225 21,960.7 -40.6
SSE Comp 2,985.7 +7.5
Shanghai A 3,127.8 +7.9
Shanghai B 271.6 +0.9
PSE Comp 0.0
KOSPI 2,070.7 +8.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

LEE'S PHARM LEE'S PHARM
Quotes 15 Minutes Delayed. Updated at 18 Sep 2019 16:08
Last (HKD): 4.580 Change: - High: 4.640 Remarks: -
Change (%): - Low: 4.490
Open 4.640 Yesterday's Close 4.580
Buy Price 4.570 Sell Price 4.580
Buy Volume ('000) 0.5 Sell Volume ('000) 5
Cumulative Volume ('000) 482 Cumulative Value 2,190,925
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.70617 Trailing EPS (HKD) e 0.55848 NAV (HKD) b 3.8262
PE a 6.486 Trailing PE f 8.201 Price / NAV b 1.1970
Dividend (HKD) d 0.117944 Cash In Hand (HKD) g 1.2490 Issued & Paid-up Shares c 592,309,000
Dividend Yield (%) d 2.575 Price / Cash In Hand g 3.667 Treasury Shares h -
Beta - 75 Daysi 0.895 R-Squared - 75 Days(%)i 8.00 Market Cap (M) 2,712.775
Beta - 500 Daysi 1.050 R-Squared - 500 Days (%)i 11.94 Enterprise Value (M) 2,236.124
Piotroski F Score 4 Exchange Code 950 Par Value ( HKD ) 0.05000
52 Weeks Volatility (%) 39.53 6-Month VWAP 4.903 Free Float (%) 50.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 Apr 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference LEE'S PHARM HKEx 2,712.775 6.486 8.201 1.1970 2.575
Industry Biotechnology HKEx 49,843.539 13.262 14.053 5.5937 2.735
Local Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Local Peer SINO BIOPHARM HKEx 135,076.224 12.606 13.010 3.9683 0.681
Local Peer WUXI BIO HKEx 97,099.387 130.002 101.632 9.9953 -
Local Peer BEIGENE HKEx 62,029.143 - - 5.1096 -
Local Peer 3SBIO HKEx 31,734.100 20.978 25.533 3.1278 -
Local Peer GENSCRIPT BIO HKEx 31,656.040 190.370 - 8.9272 -
Local Peer FRONTAGE HKEx 8,693.081 98.678 98.671 4.4992 -
Local Peer VIVA BIOTECH HKEx 7,496.719 69.898 69.898 3.8920 -
Local Peer HAOHAI BIOTEC HKEx 5,857.658 11.930 13.222 1.3791 1.598
Local Peer ASCLETIS-B HKEx 4,225.001 - - 1.0964 -
Local Peer CKLIFE SCIENCES HKEx 3,459.985 13.158 13.140 0.8287 2.778
Local Peer ESSEX BIO-TECH HKEx 2,870.883 12.423 10.968 2.7302 -
Other Local Peers UNI-BIO GROUP (HKEx), BBI LIFE SCI (HKEx), CT ENTERPRISE (HKEx), REGENT PACIFIC (HKEx), EXTRAWELL PHAR (HKEx), BIOSINO BIO-TEC (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 117,973.181 14.054 14.824 10.9295 2.818
Global Peer GILEAD SCIENCES INC NASDAQ 83,800.996 15.362 14.072 3.7054 3.488
Global Peer CSL ASX 106,433.574 39.671 39.671 14.2231 1.132
Global Peer CELGENE CORP NASDAQ 69,881.863 17.272 13.258 6.9527 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 45,238.160 21.579 20.424 8.9228 -
Global Peer ILLUMINA INC NASDAQ 43,845.690 53.082 46.744 10.1213 -
Global Peer BIOGEN INC NASDAQ 44,027.499 9.937 8.316 3.3990 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 31,662.760 12.953 15.302 3.2455 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,178.397 311.575 18.130 2.3789 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,643.355 74.821 22.055 4.9807 0.802
Other Global Peers INCYTE CORPORATION (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), SEATTLE GENETICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), EXELIXIS INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), ALKERMES PLC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), CRISPR THERAPEUTICS AG (NASDAQ), GENOMIC HEALTH INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), INSMED INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALECTOR INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VERACYTE INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), EPIZYME INC (NASDAQ), INTREXON CORP (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), OMEROS CORP (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), POLYNOVO LIMITED (ASX), HOMOLOGY MEDICINES INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ARVINAS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), NEXTCURE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CYTOKINETICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), MESOBLAST LTD (ASX), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORTEXYME INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD (ASX), MACROGENICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SYNTHORX INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), AVROBIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), RETROPHIN INC (NASDAQ), IMMUNOGEN INC (NASDAQ), PERSONALIS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), DERMIRA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MERUS B V (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), NEXT SCIENCE LTD (ASX), PROTAGONIST THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), MEDICINOVA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), KADMON HLDGS INC (NYSE), PROTHENA CORP PLC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ARDELYX INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), EIGER BIOPHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), COMPUGEN (NASDAQ), PDL BIOPHARMA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), SYNDAX PHARMACEUTICALS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), PFENEX INC (NYSE American), MOLECULAR TEMPLATES INC (NASDAQ), ATHERSYS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), DPHARMA (Bursa), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), KAMADA (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ENZO BIOCHEM INC (NYSE), X4 PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), APPLIED THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), IMV INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), CHIMERIX INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), APTOSE BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NANTKWEST INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SESEN BIO INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), HARVARD BIOSCIENCE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ADURO BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), FENNEC PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), RESAPP HEALTH LIMITED (ASX), ITERUM THERAPEUTICS PLC (NASDAQ), TREVENA INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CEL-SCI CORP (NYSE American), SELECTA BIOSCIENCES INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), INFLARX N V (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), PHYLOGICA LIMITED (ASX), NEON THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PORT (SET), NEWLINK GENETICS CORP (NASDAQ), ORGENESIS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), EQUILLIUM INC (NASDAQ), CURIS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), PLURISTEM THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ARAVIVE INC (NASDAQ), OTONOMY INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VERMILLION INC (NASDAQ), COHBAR INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), IMUGENE LIMITED (ASX), OPIANT PHARMACEUTICALS INC (NASDAQ), IBIO INC (NYSE American), IMMUTEP LTD (ASX), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), ORTHOCELL LIMITED (ASX), ORGANOVO HLDGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), DIAMEDICA THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), BIOCARDIA INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), AZURRX BIOPHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ORAGENICS INC (NYSE American), ALIMERA SCIENCES INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), BIOTRON (ASX), ZAFGEN INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SENESTECH INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), SOPHIRIS BIO INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), TOCAGEN INC (NASDAQ), RHINOMED LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOCEPT INC (NASDAQ), HISTOGENICS CORP (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), HEAT BIOLOGICS INC (NASDAQ), MEMPHASYS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), CO DIAGNOSTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ISORAY INC (NYSE American), PATRYS LIMITED (ASX), PULMATRIX INCORPORATED (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), BIONOMICS LTD (ASX), REGENEUS LTD (ASX), ADALTA LTD (ASX), DARE BIOSCIENCE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), Suntar Eco-City^ (SGX), IMMURON LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CELLMID LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BIONANO GENOMICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), NANOVIRICIDES INC (NYSE American), CLEVELAND BIOLABS INC (NASDAQ), TROVAGENE INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), VAXART INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), REXAHN PHARMACEUTICALS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BIOXYNE LIMITED (ASX), XENETIC BIOSCIENCES INC (NASDAQ), MEDIBIO LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CYCLACEL PHARMA IN (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), ADVAXIS INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), MGRC (Bursa), AVECHO BIOTECHNOLOGY LTD (ASX), MEGASUN (Bursa), OPGEN INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SPHERIX INC (NASDAQ), QT Vascular (SGX), NOVITA HEALTHCARE LTD (ASX), AIM IMMUNOTECH INC (NYSE American), CCP TECHNOLOGIES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), BPH ENERGY LIMITED (ASX), NANOLLOSE LTD (ASX), NEURALSTEM INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), ALCHEMIA LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days 0.018+0.270
+6.68 %
10 Days 0.018+0.170
+4.26 %
20 Days 0.018+0.970
+27.37 %
Medium Term Return 3 Months 0.018-0.590
-11.06 %
6 Months 0.102-2.420
-33.11 %
1 Year 0.102-2.040
-29.27 %
Long Term Return 2 Years 0.206-1.540
-21.80 %
3 Years 0.319-2.630
-32.05 %
Annualised Return Annualised --
-12.09 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 3.320 - 7.550 Change From 1 Year Low +1.260 % Change From 1 Year Low (%) +37.95
Change From 1 Year High -2.970 % Change From 1 Year High (%) -39.34
2 Years Range 3.320 - 14.700 Change From 2 Years Low +1.260 % Change From 2 Years Low (%) +37.95
Change From 2 Years High -10.120 % Change From 2 Years High (%) -68.84
5 Years Range 3.320 - 15.400 Change From 5 Years Low +1.260 % Change From 5 Years Low (%) +37.95
Change From 5 Years High -10.820 % Change From 5 Years High (%) -70.26
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture and sale of pharmaceutical products. It operates through the Proprietary Products and Licensed-in Products segments. The Proprietary Products segment involves in manufacturing and selling self-development pharmaceutical products. The Licensed-in Products segment offers trading of licensed-in pharmaceutical products. The company was founded on December 17, 2001 and is headquartered in Hong Kong.

Historical Price Data

Date Open High Low Close Volume VWAP
17 Sep 2019 4.600 4.610 4.450 4.580 568,000 4.5033
16 Sep 2019 4.750 4.780 4.500 4.590 675,500 4.6152
13 Sep 2019 4.690 4.700 4.450 4.680 534,000 4.5834
12 Sep 2019 4.580 4.660 4.470 4.590 741,500 4.5653
11 Sep 2019 4.450 4.600 4.320 4.550 1,381,500 4.5268
10 Sep 2019 4.200 4.370 4.100 4.310 816,500 4.2318
09 Sep 2019 4.350 4.380 4.070 4.130 806,000 4.1906
06 Sep 2019 4.350 4.490 4.260 4.330 1,317,000 4.3578
05 Sep 2019 4.420 4.420 4.190 4.300 1,337,000 4.2774
04 Sep 2019 4.470 4.470 4.220 4.280 1,648,500 4.3516
03 Sep 2019 3.950 4.480 3.950 4.410 4,538,000 4.2908
02 Sep 2019 3.970 3.970 3.750 3.890 617,000 3.8328
30 Aug 2019 3.610 3.920 3.600 3.800 1,622,000 3.7960
29 Aug 2019 3.650 3.650 3.450 3.560 515,500 3.5519
28 Aug 2019 3.650 3.650 3.440 3.510 1,005,500 3.5168
27 Aug 2019 3.470 3.640 3.430 3.580 1,244,000 3.5643
26 Aug 2019 3.470 3.470 3.320 3.380 1,151,000 3.4071
23 Aug 2019 3.560 3.580 3.370 3.560 1,261,000 3.4807
22 Aug 2019 3.650 3.660 3.490 3.540 426,500 3.5572
21 Aug 2019 3.690 3.720 3.580 3.630 517,500 3.6568
20 Aug 2019 3.400 3.640 3.350 3.610 2,462,000 3.5231
19 Aug 2019 3.460 3.500 3.340 3.360 1,917,942 3.4038
Summary
Current 2 Weeks
(04 Sep 2019 to 17 Sep 2019)
4.470 4.780 4.070 4.580 9,825,500 -
Previous 2 Weeks
(21 Aug 2019 to 03 Sep 2019)
3.690 4.780 3.580 4.410 12,898,000 -
4 Weeks from
(24 Jul 2019 to 20 Aug 2019)
5.170 5.170 4.070 3.610 23,496,167 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.